Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M40,778Revenue (TTM) $M190,884Net Margin (%)1.2Altman Z-Score4.4
Enterprise Value $M46,174EPS (TTM) $9.7Operating Margin %1.9Piotroski F-Score5
P/E(ttm)18.7Beneish M-Score-2.4Pre-tax Margin (%)1.7Higher ROA y-yN
Price/Book4.610-y EBITDA Growth Rate %26.5Quick Ratio0.6Cash flow > EarningsY
Price/Sales0.25-y EBITDA Growth Rate %14.9Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow22.6y-y EBITDA Growth Rate %14.2ROA % (ttm)4.1Higher Current Ratio y-yN
Dividend Yield %0.6PEG1.3ROE % (ttm)26.0Less Shares Outstanding y-yY
Payout Ratio %11.0Shares Outstanding M225ROIC % (ttm)19.5Gross Margin Increase y-yN

Gurus Latest Trades with MCK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MCKArnold Van Den Berg 2016-03-31 Buy 1.89%$150.03 - $197.23
($162.03)
$ 181.2212%New holding70,171
MCKJoel Greenblatt 2016-03-31 Add0.57%$150.03 - $197.23
($162.03)
$ 181.2212%Add 682.77%367,238
MCKWallace Weitz 2016-03-31 Buy 0.32%$150.03 - $197.23
($162.03)
$ 181.2212%New holding57,675
MCKVanguard Health Care Fund 2016-03-31 Add0.19%$150.03 - $197.23
($162.03)
$ 181.2212%Add 8.24%7,165,280
MCKCharles Brandes 2016-03-31 Buy 0.1%$150.03 - $197.23
($162.03)
$ 181.2212%New holding42,931
MCKJohn Paulson 2016-03-31 Add0.06%$150.03 - $197.23
($162.03)
$ 181.2212%Add 671.60%62,500
MCKGeorge Soros 2016-03-31 Sold Out -0.01%$150.03 - $197.23
($162.03)
$ 181.2212%Sold Out0
MCKMario Gabelli 2016-03-31 Reduce$150.03 - $197.23
($162.03)
$ 181.2212%Reduce -13.32%12,070
MCKDodge & Cox 2016-03-31 Buy $150.03 - $197.23
($162.03)
$ 181.2212%New holding2,590
MCKJoel Greenblatt 2015-12-31 Reduce-0.42%$178.8 - $200.5
($189.02)
$ 181.22-4%Reduce -83.27%46,915
MCKVanguard Health Care Fund 2015-12-31 Add0.06%$178.8 - $200.5
($189.02)
$ 181.22-4%Add 2.30%6,619,780
MCKGeorge Soros 2015-12-31 Buy 0.01%$178.8 - $200.5
($189.02)
$ 181.22-4%New holding2,100
MCKJohn Paulson 2015-12-31 Buy 0.01%$178.8 - $200.5
($189.02)
$ 181.22-4%New holding8,100
MCKMario Gabelli 2015-12-31 Reduce$178.8 - $200.5
($189.02)
$ 181.22-4%Reduce -21.33%13,925
MCKKen Fisher 2015-12-31 Sold Out $178.8 - $200.5
($188.84)
$ 181.22-4%Sold Out0
MCKLeon Cooperman 2015-09-30 Sold Out -2.48%$184.26 - $235.13
($211.95)
$ 181.22-14%Sold Out0
MCKJoel Greenblatt 2015-09-30 Add0.09%$184.26 - $235.13
($211.95)
$ 181.22-14%Add 22.00%280,458
MCKVanguard Health Care Fund 2015-09-30 Add0.05%$184.26 - $235.13
($211.95)
$ 181.22-14%Add 2.02%6,471,080
MCKMario Gabelli 2015-09-30 Add$184.26 - $235.13
($211.95)
$ 181.22-14%Add 2.31%17,700
MCKKen Fisher 2015-09-30 Buy $184.26 - $235.13
($211.95)
$ 181.22-14%New holding6,433
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MCK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MCK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HAMMERGREN JOHN HChairman, President & CEO 2016-05-25Sell37,420$182.87-0.9view
Schechter Lori A.EVP, GC & Chief Compl. Officer 2016-05-25Sell215$182.87-0.9view
JULIAN PAUL CEVP, Group President 2016-05-25Sell20,232$182.87-0.9view
Blake PatrickEVP, Group President 2016-05-25Sell6,322$182.87-0.9view
Schechter Lori A.EVP, GC & Chief Compl. Officer 2016-05-23Sell107$179.331.05view
JULIAN PAUL CEVP, Group President 2016-05-23Sell10,119$179.331.05view
HAMMERGREN JOHN HChairman, President & CEO 2016-05-23Sell18,718$179.331.05view
Blake PatrickEVP, Group President 2016-05-23Sell3,162$179.331.05view
Figueredo JorgeEVP, Human Resources 2016-05-23Sell12,250$179.31.07view
HAMMERGREN JOHN HChairman, President & CEO 2016-05-10Sell101,833$170.716.16view

Press Releases about MCK :

Quarterly/Annual Reports about MCK:

News about MCK:

Articles On GuruFocus.com
Vanguard Health Care Fund Ups Stake in High-Conviction Stocks May 10 2016 
Parnassus Fund Comments on McKesson May 09 2016 
Parnassus Fund First Quarter Commentary May 09 2016 
Wallace Weitz Comments on McKesson Apr 22 2016 
Early Oil Investor Arnold Van Den Berg Keeps Buying Energy Stocks in Q1 Apr 19 2016 
Stocks Trading Below Peter Lynch Earnings Line Mar 01 2016 
A Short-Term Problem Creates Long-Term Opportunity in Lannett Company Jan 12 2016 
Larry Robbins Buys Cigna, Monsanto and Sells Out McDonald's Dec 09 2015 
A Look at Recent Insider Trades Oct 16 2015 
McKesson Officer Sells 101,835 Shares of Company Oct 15 2015 

More From Other Websites
What Made McKesson the Top Gainer among Biotech Large-Caps? May 26 2016
McKesson Declares Quarterly Dividend May 25, 2016 May 25 2016
Joliet Radiological Service Corp. Chooses McKesson May 24 2016
MCKESSON CORP Files SEC form 8-K, Change in Directors or Principal Officers May 20 2016
Wal-Mart Ties up with McKesson to Boost Pharmacy Offerings May 18 2016
Analyst: Sourcing Agreement with Wal-Mart Gives McKesson a 'Meaningful Win' May 16 2016
Why McKesson (MCK) Stock Is Surging Today May 16 2016
Wal-Mart Pairs With McKesson to Buy Generic Drugs More Cheaply May 16 2016
Why Wal-Mart is McKesson's Best Friend May 16 2016
McKesson And Walmart Reveal Sourcing Deal For Generic Pharmaceuticals May 16 2016
Wal-Mart expands generics procurement with McKesson May 16 2016
Dominion Pathology Associates Chooses McKesson May 16 2016
McKesson and Walmart Announce Sourcing Agreement for Generic Pharmaceuticals May 16 2016
Wal-Mart partners with McKesson on generic drugs May 16 2016
McKesson and Walmart Announce Sourcing Agreement for Generic Pharmaceuticals May 16 2016
Not Messin' With McKesson (Long) May 15 2016
Silver Capital Management Trims Exposure to Its Top Picks May 14 2016
Nvidia, Apple Supplier Skyworks, Pfizer, Comcast Lead Insider Trades May 13 2016
MCKESSON CORP Financials May 11 2016
[$$] McKesson Ventures Joins Series C Round for Evariant May 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)